MENU
NVO
AS OF
Dec 24 closing price
Price
$52.56
Change
+$0.95 (+1.84%)
Capitalization
232.58B
41 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
232.58B
P/E Ratio
14.27
Total Cash
32.58B
Projected Growth
2.22
Total Debt
101.21B
Revenue
315.6B
Risk (Beta)
0.51
Dividend Yield
0.03
Total Cash/Share
7.33
Total Debt/Equity
2.39
Revenue/Share
11.20 USD as % of share price

Fundamentals

NVO
Capitalization
233B
P/E Ratio
14.27
Risk (Beta)
0.51
Dividend Yield
0.03
Total Cash
32.6B
Total Cash/Share
7.33
Total Debt
101B
Total Debt/Equity
2.39
Projected Growth (PEG Ratio)
2.22
Revenue/Share (as % of the share price)
11.20%
Revenue
316B
ROE
N/A
Book Value
170B
P/B Ratio
8.71
Cash Flow
N/A
Earnings
23.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
446M
Current Ratio
0.78
Current Revenue Per Employee
954451.70
Dividends Per Share - Security
3.73
EBITDA
151B
Float
N/A
Float - Current
N/A
Gross Income Margin
76.12
Revenue To Assets
22.81
Shares Held By Institutions
52.8B
Shares Outstanding - Current
4.44B
Total Liabilities
342B
Total Volume MTD
N/A
Value
1
Gain YTD
-37.213
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+8%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
NVO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVO showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NVO
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com